HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats.

Abstract
Uric acid and oxidative stress promote cardiovascular diseases, including atherosclerosis and hypertension. Xanthine oxidase, through which uric acid is generated, is a free-radical generating enzyme. The aim of the current study was to investigate whether allopurinol, an inhibitor of xanthine oxidase activity, affects vascular remodeling and vascular smooth muscle cell (VSMC) proliferation. In the carotid artery ligation model using spontaneously hypertensive rats (SHR), treatment with allopurinol induced a reduction in the neointima/media ratio by 27% (38.5+/-34.3% in the control group and 28.1 20.8% in the allopurinol-treated group, respectively, p<0.01) without alterations in vascular circumference at 3 weeks after ligation when compared to the control. Allopurinol lowered the serum uric acid concentration (147.0+/-3.6 micromol/l in the control group and 16.1+/-3.6 micromol/l in the allopurinol-treated group, respectively p<0.01) and xanthine oxidase activity, but not the blood pressure. In an in vitro study, high concentrations of uric acid (100 and 200 micromol/l) stimulated VSMC growth, but there was no stimulation of these cells by a low concentration of uric acid (50 micromol/I) or by any of three concentrations of xanthine (50, 100 and 200 micromol/l). In addition, allopurinol (5 micromol/I) had no effect on the cell growth. In conclusion, uric acid is a potent stimulator of VSMC proliferation, and allopurinol prevented vascular remodeling in SHR at least in part by inhibiting uric acid concentration.
AuthorsYasutaka Yamamoto, Kazuhide Ogino, Go Igawa, Takashi Matsuura, Yasuhiro Kaetsu, Shinobu Sugihara, Koichi Matsubara, Junichiro Miake, Toshihiro Hamada, Akio Yoshida, Osamu Igawa, Tetsuya Yamamoto, Chiaki Shigemasa, Ichiro Hisatome
JournalHypertension research : official journal of the Japanese Society of Hypertension (Hypertens Res) Vol. 29 Issue 11 Pg. 915-21 (Nov 2006) ISSN: 0916-9636 [Print] England
PMID17345792 (Publication Type: Journal Article)
Chemical References
  • Xanthine
  • Uric Acid
  • Allopurinol
  • Xanthine Oxidase
Topics
  • Allopurinol (pharmacology, therapeutic use)
  • Animals
  • Blood Pressure (drug effects)
  • Carotid Arteries (drug effects)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Heart Rate (drug effects)
  • Hyperplasia (drug therapy)
  • Hypertension (pathology, physiopathology)
  • Ligation
  • Male
  • Myocytes, Smooth Muscle (drug effects)
  • Rats
  • Rats, Inbred SHR
  • Tunica Media (drug effects)
  • Uric Acid (blood, pharmacology)
  • Xanthine (pharmacology)
  • Xanthine Oxidase (antagonists & inhibitors, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: